Insulet Corporation logo

Insulet Corporation (PODD)

Market Open
14 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
292. 01
+2.69
+0.93%
$
20.55B Market Cap
56.74 P/E Ratio
0% Div Yield
605,800 Volume
2.99 Eps
$ 289.32
Previous Close
Day Range
290.26 296.44
Year Range
173 329.33
Want to track PODD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 23 days
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?

Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?

Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 5 days ago
Here's Why You Should Retain PODD Stock in Your Portfolio Now

Here's Why You Should Retain PODD Stock in Your Portfolio Now

Insulet's Omnipod 5 gains traction with global expansion and rising Type 2 adoption despite economic and competitive hurdles.

Zacks | 1 month ago
Insulet Gains 78.5% in a Year: What's Driving the Stock?

Insulet Gains 78.5% in a Year: What's Driving the Stock?

PODD's shares rise on the back of Omnipod 5's growth, global expansion, and strong Q1 2025 gains despite rising operating costs and macro headwinds.

Zacks | 1 month ago
Here's Why Insulet (PODD) is a Strong Momentum Stock

Here's Why Insulet (PODD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet Corporation's NASDAQ: PODD recent outperformance has caught investors' attention and has earned it a designation as a top performer on the S&P 500.

Marketbeat | 2 months ago
Outlier Money Flows Lift Insulet

Outlier Money Flows Lift Insulet

Big Money buying shares of Insulet Corporation (PODD).

Fxempire | 2 months ago
Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

PODD delivers better-than-expected earnings and revenues in the first quarter of 2025.

Zacks | 2 months ago
S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Major U.S. equities indexes pulled back from their early gains Friday as investors wait for new developments on tariffs ahead of a weekend meeting between U.S. and Chinese officials.

Investopedia | 2 months ago
Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet Corporation (NASDAQ:PODD ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants June Lazaroff - Senior Director, IR Tim Scannell - Chair Ashley McEvoy - President and CEO Ana Chadwick - EVP and CFO Eric Benjamin - Chief Product and Customer Experience Officer Conference Call Participants Travis Steve - Bank of America Robbie Marcus - JPMorgan Jeff Johnson - Baird Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Patrick Wood - Morgan Stanley Marie Thibault - BTIG Michael Polark - Wolfe Research Matt O'Brien - Piper Sandler Steve Lichtman - Oppenheimer Issie Kirby - Redburn Atlantic Operator Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation First Quarter Earnings Call. At this time, all participants are in a listen-only mode.

Seekingalpha | 2 months ago
Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say

Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Insulet (PODD) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 2 months ago
Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates

Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates

Insulet (PODD) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.73 per share a year ago.

Zacks | 2 months ago
Loading...
Load More